Haixia Cao Selected Research

efatutazone

1/2018	Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
12/2017	PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haixia Cao Research Topics

Disease

23	Neoplasms (Cancer) 04/2022 - 12/2006
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 12/2006
9	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2014
5	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2013
4	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2019
4	Adenocarcinoma of Lung 03/2018 - 03/2017
3	Inflammation (Inflammations) 01/2020 - 01/2017
3	Pain (Aches) 07/2018 - 11/2017
3	Neoplasm Metastasis (Metastasis) 12/2017 - 02/2013
2	Fatty Liver 01/2020 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 03/2017
2	Non-alcoholic Fatty Liver Disease 01/2019 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2008
2	Gout 10/2018 - 07/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2016 - 12/2006
1	Cognitive Dysfunction 04/2022
1	Alcoholic Fatty Liver 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Carcinogenesis 01/2019
1	Liver Diseases (Liver Disease) 10/2018
1	Atherosclerosis 09/2018
1	Esophageal Stenosis (Esophageal Stricture) 12/2017
1	Fever (Fevers) 12/2017
1	Hemorrhage 12/2017
1	Hydrothorax 12/2017
1	Hypertension (High Blood Pressure) 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2017
1	Binge Drinking 07/2017
1	Liver Failure 01/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2017
1	Esophageal Neoplasms (Esophageal Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

8	Gefitinib (Iressa)FDA Link 01/2020 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2014
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2017
4	Phosphotransferases (Kinase)IBA 01/2020 - 11/2014
4	Liver X ReceptorsIBA 01/2019 - 01/2017
3	Long Noncoding RNAIBA 01/2020 - 09/2018
3	PlatinumIBA 01/2020 - 12/2006
3	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2016
3	Ethanol (Ethyl Alcohol)IBA 01/2020 - 01/2017
3	T0901317IBA 01/2019 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 10/2018 - 05/2013
3	ErbB Receptors (EGF Receptor)IBA 05/2018 - 01/2016
3	Therapeutic UsesIBA 01/2018 - 11/2015
3	PPAR gammaIBA 01/2018 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 03/2017 - 10/2008
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 01/2017
2	nedaplatinIBA 01/2020 - 05/2015
2	GW 3965IBA 01/2019 - 02/2017
2	Uric Acid (Urate)IBA 10/2018 - 07/2017
2	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 12/2006
2	Pharmaceutical PreparationsIBA 07/2018 - 01/2016
2	LigandsIBA 05/2018 - 05/2013
2	MicroRNAs (MicroRNA)IBA 03/2018 - 03/2017
2	efatutazoneIBA 01/2018 - 12/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 01/2013
1	Cyclin A2IBA 11/2020
1	CyclinsIBA 11/2020
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2020
1	platelet-derived growth factor AIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	MAP Kinase Kinase Kinase 5IBA 01/2020
1	platelet-derived growth factor ABIBA 01/2020
1	Platelet-Derived Growth FactorIBA 01/2020
1	HexanolsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	N 30IBA 10/2018
1	ATP Binding Cassette Transporter 1IBA 01/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017
1	Colchicine FDA LinkGeneric 11/2017
1	Blood Proteins (Serum Proteins)IBA 03/2017
1	Biological ProductsIBA 03/2017
1	Toll-Like Receptor 9IBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	Local AnestheticsIBA 01/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2016

Therapy/Procedure

12	Therapeutics 11/2020 - 11/2015
10	Drug Therapy (Chemotherapy) 04/2022 - 12/2006
1	Precision Medicine 01/2019
1	Immunotherapy 01/2018
1	Length of Stay 12/2017
1	Photochemotherapy (Photodynamic Therapy) 12/2017